VC Corporate Advisors Issues Corrigendum for Onyx Biotec Open Offer
Onyx Biotec Ltd · Others (Uncategorized) · 12 Nov 2026, 12:22 am
VC Corporate Advisors Issues Corrigendum for Onyx Biotec Open Offer VC Corporate Advisors submitted a Corrigendum to the Letter of Offer dated 7th Nov'26 regarding the open offer for Onyx Biotec Limited. The offer, launched by acquirers Kunal Bhardwaj, Gautam Bhardwaj, Kanhaiya Bhardwaj, and Kapil Bhardwaj, aims to acquire up to 47,14,372 equity shares (₹10 face value), representing 26.00% of total voting equity capital. The corrigendum corrects the promoter shareholding disclosure, categorizing Riya Chadha (holding 4,200 shares, 0.02%) under Promoters/Promoter Group, adjusting aggregate promoter holding to 75,65,200 shares (41.72%).
Original exchange filing (PDF)
More announcements from Onyx Biotec Ltd
- Onyx Biotec Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 · 14 Nov 2026
- Onyx Biotec Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 14 Nov 2026
- Onyx Biotec Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . · 14 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 · 14 Nov 2026
- VC Corporate Advisors Private Limited has Submitted to the Exchange a copy of offer opening public announcement cum corrigendum to the detailed public statement to the public shareholders of the Onyx Biotec Limited (Target Company). · 14 Oct 2026
- Onyx Biotec Limited has informed regarding Submission of the Non-Applicability of the provisions relating to Corporate Governance as specified in the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. · 14 Oct 2026
- Onyx Biotec Limited has Submitted to the Exchange a newspaper copy of the Recommendation of the Independent Director Committee ("IDC") of the company in relation to the Open Offer made by Mr. Kunal Bhardwaj ( Acquirer 1 ), Mr. Gautam Bhardwaj ( Acquirer 2 ), Mr. Kanhaiya Bhardwaj ( Acquirer 3 ) and Mr. Kapil Bhardwaj ( Acquirer 4 ) (hereinafter collectively referred to as the Acquirers ) to the public shareholders of the company under Regulation 26(7) of SEBI (SAST) Regulations, 2011 and subseq · 08 Oct 2026
- Onyx Biotec Limited has Submitted to the Exchange the outcome of the meeting of the committee of the Independent Directors held today i.e. October 07, 2026 to give their recomendation in the Open Offer of Onyx Biotec Limited in compliance with Regulation 26(7) of the SEBI (SAST) Regulations, 2011and subsequent Amendments thereto. · 08 Oct 2026
